Plitidepsin induces apoptosis in glioma cells through β-TrCP-mediated ubiquitination and degradation of BMI1
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05507-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Yiting Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ningbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, 3…. Hauptthemen laut MEDLINE: Apoptosis, Polycomb Repressive Complex 1, Glioma, Depsipeptides. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Glioma remains a challenging malignancy with limited therapeutic options. This study investigates the antitumor efficacy and molecular mechanisms of plitidepsin, a marine-derived antitumor agent, in gliomas. In vitro experiments demonstrated that plitidepsin dose- and time-dependently inhibited viability and induced apoptosis in U87 and U251 glioma cells, accompanied by caspase-3 activation, cytochrome c/Smac release, and upregulation of the pro-apoptotic protein NOXA. Mechanistically, plitidepsin triggered intrinsic apoptosis by transcriptionally activating NOXA via suppression of BMI1, a polycomb repressor complex protein. Proteomic and functional studies revealed that plitidepsin promoted β-transducin repeat-containing protein (β-TrCP)-mediated K48-linked polyubiquitination and proteasomal degradation of BMI1, dependent on its conserved DSG(X)₂ + n(S) degron motif. Silencing BMI1 potentiated plitidepsin-induced apoptosis, while BMI1 overexpression conferred resistance. In vivo, plitidepsin significantly suppressed U87 xenograft tumor growth, correlating with reduced BMI1 expression, elevated NOXA levels, and decreased proliferation. These findings identify plitidepsin as a potent inducer of β-TrCP-dependent BMI1 degradation, unveiling a novel mechanism linking BMI1-NOXA axis activation to intrinsic apoptosis in gliomas. This study highlights plitidepsin's therapeutic potential for glioma treatment through targeting the ubiquitin-proteasome pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ningbo Key Laboratory of Nervous System and Brain Function, Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, Zhejiang, China.
- Department of Neurosurgery, Ningbo No.7 Hospital, Zhejiang Province, Ningbo, China.
- Department of Rehabilitation, Ningbo Zhenhai Longsai Hospital, Zhejiang Province, Ningbo, China.
- Department of Neurosurgery, Xinchang County People's Hospital, Shaoxing, Zhejiang, China. yyw23164@163.com.
Zitieren
APA
Wei, Y., Wan, Y., Duan, S., Gong, F., & Yang, Y. (2026). Plitidepsin induces apoptosis in glioma cells through β-TrCP-mediated ubiquitination and degradation of BMI1. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05507-2
Vancouver
Wei Y, Wan Y, Duan S, Gong F, Yang Y. Plitidepsin induces apoptosis in glioma cells through β-TrCP-mediated ubiquitination and degradation of BMI1. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05507-2
BibTeX
@article{Wei2026,
author = {Wei, Yiting and Wan, Yuling and Duan, Shilong and Gong, Fanyong and Yang, Yuewei},
title = {Plitidepsin induces apoptosis in glioma cells through β-TrCP-mediated ubiquitination and degradation of BMI1},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05507-2}
}
EUVIMED